1. Bioorg Med Chem Lett. 2007 Aug 1;17(15):4232-41. doi: 
10.1016/j.bmcl.2007.05.034. Epub 2007 May 17.

Discovery of cyclopentane- and cyclohexane-trans-1,3-diamines as potent 
melanin-concentrating hormone receptor 1 antagonists.

Giordanetto F(1), Karlsson O, Lindberg J, Larsson LO, Linusson A, Evertsson E, 
Morgan DG, Inghardt T.

Author information:
(1)Lead Generation, Computational Chemistry, AstraZeneca R&D Mölndal, SE-431 83 
Mölndal, Sweden. fabrizio.giordanetto@astrazeneca.com

We herein report the optimization of cyclopentane- and cyclohexane-1,3-diamine 
derivatives as novel and potent MCH-R1 antagonists. Structural modifications of 
the 2-amino-quinoline and thiophene moieties found in the initial lead compound 
served to improve its metabolic stability profile and MCH-R1 affinity, and 
revealed unprecedented SAR when compared to other 2-amino-quinoline-containing 
MCH-R1 antagonists.

DOI: 10.1016/j.bmcl.2007.05.034
PMID: 17532215 [Indexed for MEDLINE]
